IPOPLUS

₹2,197.6

▲ +18.9 +0.87%

17 Jun 2026

NSE Listed

Gland Pharma Limited (GLAND)

Volume: 6,95,609Avg Vol 1W: 8,86,450.6Avg Vol 1M: 10,41,548.6552W Range:₹1,573.6₹2,396
NSE BSE
₹2,197.6▲ 0.87%
Key Ratios
Updated 4h ago
Market Cap₹37,299 Cr
Current Price₹2,197.6
Previous Close₹2,178.7
High / Low (52w)₹2,396 / ₹1,573.6
Volume6,95,609
Avg Vol (1W)8,86,450.6
Avg Vol (1M)10,41,548.65
Stock P/E101.63
Book Value₹628.52
Dividend Yield0.9%
ROE9.9%
ROA8.2%
Revenue (TTM)₹5,830 Cr
Revenue Growth-0.8%
Profit Margin16%
Total Debt₹78 Cr
Shares Outstanding16 Cr
Face Value₹1
EPS (TTM)₹22.26
P/B3.6
Debt / Equity0.03
50 DMA₹1,981.5
200 DMA₹1,853.29
Day change+0.87%
Price Chart
₹2,197.6▲ 26.15% · 1Y
₹2334₹159671.3L
2025-06-17
2026-06-12

20-day avg volume: 10.4L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 23% YoY.
  • Stock trades at a high P/E of 102.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹1,402 Cr₹1,406 Cr₹1,384 Cr₹1,425 Cr₹1,506 Cr₹1,487 Cr₹1,695 Cr₹1,743 Cr
EBITDA₹224 Cr₹263 Cr₹322 Cr₹296 Cr₹324 Cr₹292 Cr₹390 Cr₹516 Cr
Net Profit₹144 Cr₹164 Cr₹205 Cr₹187 Cr₹215 Cr₹184 Cr₹261 Cr₹367 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹2,772 Cr₹3,598 Cr₹4,625 Cr₹3,865 Cr₹5,835 Cr₹5,830 Cr
EBITDA₹1,000 Cr₹1,338 Cr₹1,624 Cr₹1,118 Cr₹1,159 Cr₹1,105 Cr
Net Profit₹773 Cr₹997 Cr₹1,212 Cr₹781 Cr₹772 Cr₹699 Cr
EPS——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹4,086 Cr₹6,496 Cr₹7,834 Cr₹8,778 Cr₹10,661 Cr₹11,225 Cr
Total Liabilities₹440 Cr₹593 Cr₹676 Cr₹819 Cr₹1,937 Cr₹2,074 Cr
Equity₹3,646 Cr₹5,903 Cr₹7,158 Cr₹7,959 Cr₹8,724 Cr₹9,151 Cr
Total Debt₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹107 Cr₹78 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹945 Cr₹916 Cr₹1,197 Cr₹675 Cr₹1,303 Cr₹1,269 Cr
Investing₹-766 Cr₹-1,524 Cr₹-1,003 Cr₹1,208 Cr₹-1,757 Cr₹1,705 Cr
Financing₹-7 Cr₹1,238 Cr₹35 Cr₹15 Cr₹-799 Cr₹-433 Cr
Free Cash Flow₹945 Cr₹916 Cr₹1,197 Cr₹675 Cr₹1,303 Cr₹1,269 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search